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ABSTRACT Deamination of 5-methylcytosine residues in
DNA gives rise to the GyT mismatched base pair. In humans
this lesion is repaired by a mismatch-specific thymine DNA
glycosylase (TDG or GyT glycosylase), which catalyzes spe-
cific excision of the thymine base through N-glycosidic bond
hydrolysis. Unlike other DNA glycosylases, TDG recognizes an
aberrant pairing of two normal bases rather than a damaged
base per se. An important structural issue is thus to under-
stand how the enzyme specifically targets the T (or U) residue
of the mismatched base pair. Our approach toward the study
of substrate recognition and processing by catalytic DNA
binding proteins has been to modify the substrate so as to
preserve recognition of the base but to prevent its excision.
Here we report that replacement of 2*-hydrogen atoms with
f luorine in the substrate 2*-deoxyguridine (dU) residue ab-
rogates glycosidic bond cleavage, thereby leading to the for-
mation of a tight, specific glycosylase–DNA complex. Bio-
chemical characterization of these complexes reveals that the
enzyme protects an '20-bp stretch of the substrate from
DNase I cleavage, and directly contacts a G residue on the 3*
side of the mismatched U derivative. These studies provide a
mechanistic rationale for the preferential repair of deami-
nated CpG sites and pave the way for future high-resolution
studies of TDG bound to DNA.
In the cell, DNA is continuously subjected to damage arising
from the attack of various endogenous and exogenous chem-
ical agents. For example, DNA bases having exocyclic amino
groups are subject to spontaneous hydrolytic deamination (1).
The highest rates of deamination are observed for cytosine and
5-methylcytosine (m5C), resulting in the formation of UyGand
TyGmispairs, respectively, which give rise to C3 T transition
mutations upon replication. In most cases, the repair of
29-deoxyguridine (dU) residues is initiated by uracil DNA
glycosylase, which catalyzes the hydrolytic cleavage of the
N-glycosidic bond linking uracil to the sugar moiety (2). The
abasic (AP) site generated by the action of uracil DNA
glycosylase and other monofunctional glycosylases is further
processed by the AP excision repair machinery, culminating in
the restoration of the original DNA sequence.Many organisms
possess not only C but also m5C in their genomes; in mammals,
this minor fifth base serves a profound role in embryonic
development and transcriptional regulation (3). Whereas the
deamination of C produces an aberrant base (U), deamination
of m5C produces a normal base, T. Unlike other T residues in
the genome, however, those generated through deamination of
C are mispaired with G.
The first clue to the presence of a dedicated repair system for
deaminated m5C residues came with the discovery of an activity
that catalyzes the selective cleavage of the glycosidic bond of a T
residue in a GyT mismatch in human nuclear cell extracts (4, 5).
The enzyme responsible for this activity, a mismatch-specific
thymine DNA glycosylase (TDG), was subsequently purified
from HeLa cells and characterized biochemically (6, 7). In
addition toGyT pairs, the enzyme acts on othermismatches, with
the following order of reactivity: GyU . GyT .. CyT . TyT.
The cloning of TDGrevealed a 46-kDa proteinwith no homology
to other known proteins (8, 9).
Cytosine methylation in vertebrates takes place exclusively
in the 59-CpG dinucleotide, deamination of which produces
59-TpG. This raises the question of whether TDG acts pref-
erentially on GyT mispairs that arise in the context of the CpG
sequences. The effect of the base neighboring the GyT mis-
match on the rates of excision repair by TDG has been
investigated in the laboratories of Day and Karran and the
following sequence preference has been found: CpGyT ..
TpGyT . GpGyT . ApGyT (10–13). Thus, TDG exhibits a
clear preference for GyT mispairs in CpG sequences. The
functional groups of the GyT mismatch essential for recogni-
tion by TDG have been examined through cleavage assays
using chemically modified substrates. Oligonucleotides con-
taining O6-meGyT, 2-amino-6-methylpurineyT, and 6-thio-
guanineyT mispairs are substrates for the TDG, while oligo-
nucleotides containing 2,6-diaminopurineyT, 2-aminopu-
rineyT, and GyO4-meT are not (13–15).
While these studies have shed light on the sequence pref-
erence and substrate specificity of TDG, the structural basis
for mismatch recognition and catalysis by TDG remains poorly
understood. We have developed a general approach for the
study of damage recognition by DNA repair enzymes, which
centers on the design and synthesis of substrate-like molecules
that are recognized but not cleaved by DNA glycosylases. The
interaction of base excision repair enzymes with these modi-
fied DNA molecules leads to the formation of stable glycosy-
lase–DNA complexes, which are amenable to structural and
biochemical characterization. Previously, we have employed
the concepts of transition state mimicry (16) and transition
state destabilization (17) to separate binding from catalysis by
the Escherichia coli and mammalian 3-methyladenine DNA
glycosylases [3-methyladenine DNA glycosylase II (AlkA) and
3-methyladenine DNA glycosylase (ANPG), respectively].
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Here we use the transition state destabilization approach to
design and synthesize inhibitors of TDG. We report the
characterization of the resulting stable TDG–DNA complexes
using a variety of biochemical assays.
MATERIALS AND METHODS
Recombinant G-T glycosylase was overexpressed in E. coli and
purified as described (8). All reagents and solvents used were
of analytical purity. T4 polynucleotide kinase and Klenow
fragment were obtained from GIBCO, DNase from Sigma,
and [a-32P]dCTP, [a-32P]dATP, and [g-32P]dATP from Du-
PontyNEN. Standard manipulations (end-labeling reactions,
DNA precipitations, gel electrophoresis) were carried out
using routine procedures (18), unless otherwise noted. A
FUJIX (Tokyo) BAS 2000 PhosphorImager was used for
radioactivity quantification.
Oligonucleotide Synthesis, Purification and 32P End-
Labeling. 29-Deoxy-29-f luorouridine (aFU, 1; see Fig. 1) (19,
20), 1-(29-deoxy-29-f luoro b-D-arabinofuranosyl)-uracil (bFU,
2) (21), and 29-deoxy-29,29-dif luorouridine (diFU, 3) (22) were
synthesized according to published procedures. The 59-
hydroxyl group of the nucleosides was protected as the dime-
thoxytrityl ether, and the 39-hydroxyl group was transformed
into a b-cyanoethyl-N,N9-diisopropyl-phophoramidite group
using standard procedures (23). The identity of the products
was established using 1H and 31P-NMR spectroscopy and fast
atom bombardment mass spectroscopy. Oligonucleotides were
synthesized using standard solid phase procedures on an
Applied Biosystems model 392 DNAyRNA synthesizer. The
oligonucleotides were deprotected by treatment with concen-
trated ammonium hydroxide (12 hr, 558C) and purified by
denaturing gel electrophoresis. Enzymatic nucleotide diges-
tion analysis was carried out as described (24) and revealed the
presence of dU, aFU, bFU, and diFU in the expected
amounts. Oligonucleotides containing the following sequences
were synthesized:
The 25-mer oligonucleotides were end-labeled by incubating
the U-containing strand of GyU, GyaFU, GybFU, and GydiFU
25-mer with T4 polynucleotide kinase and [g-32P]ATP followed
by annealing to a 10-fold excess of unlabeledG-containing strand
in 10mMTriszHCl, pH8y1mMEDTAy100mMNaCl by heating
to 908C for 5 min and slow cooling to room temperature. The
GybFU, CpGybFU, GpGybFU, and 5 meCpGybFU 54-mer
were 39 end-labeled by filling in 59-overhangs with [a-32P]dCTP
(to label thebFUstrand) and [a-32P]dATP (to label theG strand)
and Klenow fragment. The labeled DNA was purified by elec-
trophoresis on a 5% native polyacrylamide using 0.53 TBE
buffer (0.045 M Tris-borate, pH 8y1 mM EDTA) and the bands
containing DNA were excised and the DNA isolated by electro-
elution.
Cleavage Assays. The standard reaction mixture (20 ml)
contained 25 mM HepeszKOH (pH 7.8), 1 mM EDTA, 1 mM
DTT, 8 fmol of 59 32P-end-labeled GyU, GyaFU, GybFU, and
GydiFU 25-mer, and 6 fmol of TDG. The mixture was
incubated at 378C for various amounts of time and quenched
by addition of 2 ml stop solution (1 mg/ml salmon sperm
DNAy1 M NaCly1 mg/ml BSA) and precipitation with 60 ml
100% ethanol. The mixture was then incubated with 100 ml of
1 M piperidine at 908C for 30 min. The solution was lyophi-
lized, and the pellet dissolved in formamide loading dye. An
aliquot was analyzed by electrophoresis on a 20% denaturing
polyacrylamide gel for 3 hr at 300 V. The bands were visualized
by exposing to film or a Fuji image plate.
Band-Shift Assays. The standard binding reaction mixture
(20 ml) contained 25 mMHepeszKOH (pH 7.8), 1 mM EDTA,
1 mMDTT, 100 mMNaCl, 0.1 mgyml BSA, 7.5% glycerol, and
various amount of TDG and 59 32P-end-labeled GyU, GyaFU,
GybFU, and GydiFU 25-mer or the 39 32P-end-labeled CpGy
bFU, GpGybFU, and m5CpGybFU 54-mer. After incubation
for 20 min at room temperature an aliquot was analyzed by
electrophoresis on a 6% nondenaturing polyacrylamide gel
using 0.53TBE buffer at 150 V for 1.5 hr at room temperature.
The gels were dried and exposed to film and to a Fuji image
plate for quantification of the bands on a PhosphorImager. For
competition assays 4 fmol of 59 32P-end-labeled oligonucleo-
tide was used together with 400 fmol of unlabeled specific
(UyG, aFUyG, bFUyG, or diFUyG 25-mer) or nonspecific
(unmodified 25-mer duplex) competitor. TDG (16 fmol) was
added last. For the determination of the thermodynamic
dissociation constant (Kd), 0.1 fmol of labeled oligonucleotide
was used with various amounts of TDG. The Kd 5 [pro-
tein][DNA]y[protein–DNA complex] was measured as the
concentration of the protein at which half of the target DNA
is bound. The data from four titration gels were averaged to
obtain the reported Kd values. The exact concentration of
active enzyme was determined by titrating the oligonucleotide
under stoichiometric conditions ([DNA] 5 10 nM .. Kd).
Most of the oligonucleotide used in this assay was unlabeled.
The DNA of the TDG–DNA complex in the band-shift gels
was analyzed as follows: The bands were excised and the DNA
isolated by electroelution. The isolated oligonucleotide was
then treated with piperidine and analyzed on a 20% denaturing
gel as described for the cleavage assays.
DNase I Footprinting Assays. A total of 10–20 fmol of the
39 end-labeled GybFU 54-mer was incubated with 5–150 fmol
of TDG at room temperature for 15 min in a volume of 25 ml
containing 25 mM HepeszKOH (pH 7.8), 1 mM DTT, 1 mM
EDTA, 100 mM NaCl, 250 mgyml BSA, 5 mgyml polyzd(IC), 5
mM MgCl2, and 1 mM CaCl2. The equilibrated mixture (5 ml)
was analyzed by electrophoresis on a 6% nondenaturing
polyacrylamide gel using 0.53 TBE buffer to detect the
formation of a TDG–DNA complex. The remaining 20 ml were
incubated with 20 mg DNase I for 5 min at room temperature
and the reaction quenched by addition of 4 ml of 100 mM
EDTA and heating to 908C for 5 min. The DNA was ethanol
precipitated and dissolved in formamide loading buffer, and an
aliquot was analyzed by electrophoresis on a 20% sequencing
gel. The gels were dried and exposed to film and to a Fuji image
plate. The A- and G-specific sequencing reactions were carried
out as described (25, 26).
Dimethyl Sulfate Interference Footprinting. The CpGybFU
54-mer was treated with dimethyl sulfate as described (26). A
total of $20 fmol of the methylated duplex was used in a band
shift assay using 4–128 fmol of TDG. The bands containing
bound and unbound DNA were excised, the DNA recovered
by electroelution and treated with piperidine to affect strand
cleavage. An aliquot was analyzed by electrophoresis on a 20%
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sequencing gel. The gels were dried and exposed to film and
to a Fuji image plate.
RESULTS
Design and Synthesis of TDG Inhibitors.We have reported a
strategy for DNA glycosylase inhibition based on transition state
destabilization, and employed this approach in the design of
oligonucleotides that bind tightly to the mammalian 3-methylad-
enine glycosylase ANPG (17). In the present study, we have
examined the possibility of inhibiting TDG through transition
state destabilization. Our mechanism-based approach centers on
the fact that significant charge accumulates on the ribose ring of
the substrate (notably atO-19 andC-19) during the transition state
of the glycosylase reaction. Introduction of electron-withdrawing
groups at the 29 position is expected to increase the positive
charge at C-19, thereby destabilizing the transition state and
decreasing the reaction rate. It was thus anticipated that intro-
duction of fluoride atoms in the 29 position of deoxyuridine
residues in a GyU mismatch would dramatically stabilize the
glycosidic bond toward the cleavage reaction catalyzed by TDG.
In the case of ANPG, substitution of the substrate 29-bH with F
(arabino-configured fluorosugar) led to complete inhibition of
enzymatic processing (17).However, T4 endonucleaseVwas able
to process a substrate having a 29-aF (ribo-configured fluoro-
sugar), albeit at a reduced rate (27). We therefore decided to
examine directly the influence of stereochemical configuration on
the inhibition of TDG by fluoronucleosides in DNA. Oligonu-
cleotides containing uracil derivatives bearing all possible fluo-
rine substitution patterns at the 29 position were synthesized (Fig.
1B): aFU (1) (19, 20), bFU (2) (21), and diFU (3) (22). These
fluoronucleotides were converted into the corresponding phos-
phoramidites and incorporated into DNA through solid phase
synthesis.
GyaFU, GybFU, and GydiFU Mismatches Are Not Cleaved
by TDG.Our first objective was to compare the ability of TDG
to catalyze the glycosidic bond cleavage of native and fluori-
nated U residues in GyU mismatches. The reaction catalyzed
by TDG generates an AP site in DNA, which can be specifically
cleaved with aqueous piperidine. The cleavage product can be
detected on the basis of its increased mobility in denaturing
polyacrylamide gel electrophoresis relative to the intact DNA
strand. When the GyU 25-mer was incubated with TDG for
varying amounts of time and then treated with piperidine,
time-dependent appearance of the expected cleavage product
was observed (Fig. 2, lanes 1–3). By contrast, no cleavage was
observed when 25-mer duplexes containing GyaFU, GybFU,
or GydiFU mismatches were incubated with TDG, even after
24 hr of incubation (Fig. 2, lanes 4–12).
The failure to observe an 11-mer product in cleavage assays
using potential inhibitors could in principle result from the
inability of piperidine to cleave 29-fluorinated AP sites. To
differentiate between these two possibilities, we treated 25-mer
containing dU, aFU, and bFU with hydrazine under Maxam–
Gilbert sequencing conditions, which degrades the uracil base (as
well as the thymine and cytidine bases). Subsequent treatment
with piperidine caused efficient cleavage of native and 29-
monofluorinated AP sites, as evidenced by analysis of the strand
scission products on a DNA sequencing gel (data not shown).
Having validated the piperidine cleavage assay foraFUandbFU,
we thus conclude that TDG is unable to catalyze glycosidic bond
cleavage of oligonucleotides containing the GyaFU and G/bFU
mismatches. As 29,29-difluorinated AP sites were not cleaved
efficiently by piperidine, we are unable to rule out the possibility
that diFU is a substrate for TDG. However, it seems unlikely that
diFU would be a TDG substrate, considering that neither of the
two monofluorinated derivatives are processed by the enzyme.
Specificity of the Binding Interaction Between TDG and the
Inhibitors. The inability of TDG to process 29-fluorinated dU
derivatives could result from either the intended effect on tran-
sition state energetics, or alternatively, from interference of the
enzyme binding to the modified substrates. To differentiate these
two possibilities, we carried out electrophoretic mobility shift
assays (EMSA) (28), which detect the binding of proteins to
DNA. As shown in Fig. 3, TDG binds theGyU,GyaFU,GybFU,
and GydiFU 25-mer (lanes 2, 6, 10, and 14, respectively). The
binding of GyU, GybFU, and GydiFU 25-mer is highly specific,
as judged by the resistance of the complexes to competition by a
100-fold excess of an unlabeled unmodified 25-mer duplex (lanes
4, 12, and 16, respectively), but susceptibility to specific compe-
tition by a 100-fold excess of unlabeledGyU,GybFU, orGydiFU
25-mer (lanes 3, 11, and 15, respectively). The binding of GyaFU
FIG. 1. (A) Deamination of m5C leads to a GyT mismatch. TDG
catalyzes the glycosidic bond hydrolysis of a T residue in a GyT
mismatch resulting in the formation of an AP site. TDG has a sequence
preference for GyT mismatches that arise in the context of CpG
sequences. (B) Substrates and inhibitors for TDG: GyT and GyU
mismatches are the main substrates for TDG. Substitution of a dU
residue with a dU residue containing a 29-f luorine substituent results
in a species containing a glycosidic bond with increased stability that
is no longer cleavable by TDG.
FIG. 2. Cleavage assay to detect the processing of GyU, GyaFU,
GybFU, or GydiFU 25-mer by TDG. Substrate concentrations, 0.4 nM;
TDG concentration, 0.3 nM. The 11-mer product that results from
processing of the substrate by TDG followed by piperidine-mediated
strand scission was identified by comparison with an authentic standard.
The asterisks denote the 59 32P-end-labeled strand.
FIG. 3. EMSA assay to detect specific binding of GyU, GyaFU,
GybFU, or GydiFU 25-mer to TDG. Oligonucleotide concentration,
0.2 nM; TDG concentration, lanes 1, 5, 9, and 13, no protein; all other
lanes, 0.8 nM; concentration of unlabeled competitor oligonucleotide
in lanes 3, 4, 7, 8, 11, 12, 15, and 16, 20 nM. The asterisks denote the
59 32P-end-labeled strand. The base indicated for the competitors is
paired to a G residue in the central position of a 25-mer duplex with
identical sequence to the labeled oligonucleotide.
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25-mer to TDG is less specific, since it is susceptible to compe-
tition by both specific (GyaFU-containing) and nonspecific com-
petitor (Fig. 3, lanes 7 and 8).
The interaction of GyU, GyaFU, GybFU, and GydiFU
25-mer with TDG was quantified through EMSA titration
experiments, the results of which are summarized in Table 1.
All three modified substrates bind TDG tightly, with affinities
in the 10210 range. Overall, the values of the dissociation
constants mirror the results from the competition experiments:
the dissociation constant for the GybFU and GydiFU 25-mer
are about 2-fold lower than the dissociation constants for the
GyaFU 25-mer. These data indicate that the substitution
pattern of the fluorine atoms in the 29 position influences the
strength of the binding interaction. The stereochemical spec-
ificity of the binding interaction might result in part from
effects of fluorination on the conformational state of the
sugar, as the 29-a-f luoro substituent is known to shift the
preferred sugar pucker toward the 39-endo conformer (19, 20).
Analysis of the bands of the TDG–DNA complex in the gel
revealed that the three modified oligonucleotides were intact,
while the oligonucleotide containing the unmodified GyU
substrate was partially incised. These data are consistent with
the tight binding of TDG to various AP site analogs (O.D.S.,
P.G., J.J., and G.L.V., unpublished data), and indicates that
TDG can remain bound to the AP site product after catalyzing
glycosidic bond cleavage.
BiochemicalMapping of the TDG–DNA Interface.Access to
inhibitors that form long-lived noncovalent complexes with
TDG enabled us to map the binding interactions of the
glycosylase with DNA. We first used DNase I footprinting
assays (29) to analyze the binding of TDG to a 54-mer
containing a centrally located GybFU. Increasing amounts of
TDG were incubated with the GybFU 54-mer, then DNase I
was added to effect strand cleavage at accessible phosphates
(Fig. 4A). The binding of TDG to the 54-mer specifically
protected an area of 14 nucleotides on the bFU strand and an
area of 19 nucleotides on the G strand centered around the
mismatch from cleavage by DNase I.
TDG prefers G opposite T (or U) in mismatches, and also
prefers GyT (or GyU) mismatches that arise in the context of
a m5CpG site. This specificity might result from direct inter-
actions between the glycosylase and G residues opposite the
substrate T residue or 39 to it. To detect interaction between
TDG and G residues in the major groove, we employed a
54-mer oligonucleotide containing a GybFU mismatch in a
CpG sequence (CpGybFU 54-mer, Fig. 4B) in a methylation
interference footprinting assay (30). Strong methylation inter-
ference was observed in the CpGybFU 54-mer (Fig. 4B, lanes
3 and 4) at the G residue immediately 39 to the mismatched
bFU residue. Interestingly, interference was not observed at
the G mispaired to the bFU residue (Fig. 4B, lanes 7 and 8).
These data suggest that TDGmakes a specific contact with the
G residue on the 39 side of the substrate base, but does not
recognize the mismatched G residue at its N7 position. Con-
sistent with this interpretation, little or no interference was
observed with a control oligonucleotide containing a GybFU
mismatch in a GpG sequence (GpGybFU 54-mer, data not
shown).
To see if this specific contact to a G residue contributes
energetically to the interaction between TDG and our inhib-
itors we determined the dissociation constants of TDG bound
to the CpGybFU and GpGybFU 54-mer. We also synthesized
a duplex containing a m5C in the CpG sequence (5meCpGy
bFU) to see if TDG has an increased affinity for mismatches
arising in the context of doubly methylated CpG sequences. As
shown in Table 2, the CpGybFU and 5meCpGybFU 54-mer
bind TDG about 2-fold stronger than the GpGybFU 54-mer.
These results indicate that the contact to the G residue
observed in the methylation interference assay contributes
energetically to the interaction between TDG and DNA.
Furthermore, TDG binds mismatches in the context of a singly
or doubly methylated CpG sequence with the same affinity.
The binding of TDG to its target DNA therefore appears to be
dependent on the sequence context of the mismatch, but not
on its methylation state.
DISCUSSION
Spontaneous deamination of Gzm5C base pairs generates the
GyTmispair, in which neither base is abnormal, but the two bases
do not form a standard Watson–Crick pair. Unlike GyT mis-
matches that arise during replication, in which eitherGorT could
have been misincorporated, those that are generated through
hydrolytic deamination of Gzm5C invariably possess an erroneous
T residue. To counter the potentially mutagenic effects of m5C
deamination, mammalian cells express TDG, an N-glycosylase
that specifically targets GyT mispairs, cleaving the glycosidic
bond of the T residue only (6). TDG shows strong discrimination
against native AzT base pairs. On the other hand, TDG appears
not to discriminate betweenGyT andGyUmispairs (7). Our goal
is to understand the molecular mechanisms by which TDG
achieves specificity forGyTmispairs overAzTandGzCbase pairs,
and catalyzes precise excision of the mispaired T. Although
studies using modified substrates have provided insight into the
basis for substrate recognition by TDG (13–15), a deeper under-
standing of GyT excision repair will require studies of stable
TDG–DNA complexes. The aim of the present study was to
obtain such a complex and to probe the mechanism of GyT
mismatch recognition by TDG.
One approach toward obtaining stable glycosylase–DNA com-
plexes involves mutation of active site residues in the enzyme so
as to eliminate catalytic activity, while retaining substrate recog-
nition. This strategy has been used to crystallize a T4 Endonu-
clease Vmutant bound to DNA containing a thymine dimer (31)
and a uracil DNA glycosylase double mutant bound to a product
complex (32). An alternative and complementary approach
involves the design and synthesis ofmodifiedDNA substrates that
bind glycosylases specifically but fail to undergo enzymatic pro-
cessing. For those glycosylases in which active site residues have
not yet been identified, the substrate-modification approach can
provide a direct inroad, because it only requires knowledge of the
enzyme reaction mechanism and structure of the substrate. We
have previously described two distinct mechanism-based ap-
proaches for designing glycosylase inhibitors, one involving tran-
sition state mimicry (16) and the other relying on transition state
destabilization (17). Application of these approaches to E. coli
AlkA (16) and the humanANPG (17), respectively, has led to the
design of modified oligonucleotides that bind these enzymes with
picomolar affinity.
Here we have used the concept of transition state destabi-
lization to design a series of inhibitors for the human TDG
enzyme. The transition state for N-glycosyl transfer reactions
is characterized by the accumulation of substantial positive
Table 1. Dissociation constants (Kd) for the binding of
oligonucleotides containing GyU, GyaFU, GybFU, or GydiFU
mismatches to TDG
Kd, pM
Base
pair
180 UyG
250 aFUyG
125 bFUyG
130 diFUyG
The Kd values were obtained by EMSA from the averaged data of
four sets of titration gels. The number of active enzyme molecules in
our preparation was determined by titrating the enzyme with the
GybFU-oligo under stochiometric conditions (oligonucleotide con-
centration 5 10 nM . Kd). The equilibrium lies entirely on the side
of the protein–DNA complex under these conditions, and the number
of active enzyme molecules can be directly titrated.
Biochemistry: Scha¨rer et al. Proc. Natl. Acad. Sci. USA 94 (1997) 4881
charge on the sugar, especially at the anomeric carbon (C19)
and ring oxygen (O19). It follows that attachment of electron-
withdrawing substituents, such as fluorine, on the ring should
increase the partial positive charge accumulated in the tran-
sition state and thereby decrease the reaction rate. Consistent
with this notion, the presence of electron-withdrawing sub-
stituents at the 29 position of nucleosides is known to increase
the stability of the glycosidic bond toward hydrolysis (33, 34).
It remained to be seen whether TDG would tolerate substi-
tution of one or both 29-hydrogen in its substrates, and whether
the degree of transition state destabilization would be suffi-
cient to suppress the glycosidic bond hydrolysis altogether. The
substitution of fluorine for hydrogen has been widely em-
ployed in mechanistic enzymology, since the two elements are
virtually opposite in electronegativity, yet have similar bond
lengths (C-F vs. C-H, 1.38 vs. 1.09 Å) and van der Waals radii
(2CF3 vs. CH3, 2.7 vs. 2.0 Å). Thus, substituting fluorine for
hydrogen can profoundly change the electronic properties of a
molecule, while barely affecting its steric properties.
In the present study, we have analyzed the effect of fluorine
replacement on catalysis and DNA binding by TDG. Oligonu-
cleotides containing bFU and diFU mismatched with G bind
TDG with high affinity and specificity, but are not detectably
cleaved by the enzyme. Oligonucleotides containing aFU mis-
matched to G are also not processed by TDG, but bind the
enzyme with lower strength and specificity, perhaps owing to a
shift in the preferred sugar conformation (19, 20). Importantly,
the complexes of TDG with oligonucleotides containing GybFU
andGydiFU rival in affinity and specificity those formed between
transcription factors and their cognate DNA sites, hence the
glycosylase–inhibitor complexes should be amenable to high-
resolution structural analysis.
The interaction ofTDGwithGyTmismatcheswas then probed
by DNase I footprinting and methylation interference analysis,
FIG. 4. (A)DNase I footprinting protection assay ofTDGbound to theGybFU54-mer. Parts of the sequences are shownalong the gel. Themismatched
bases are denoted by arrows and the region protected from DNase I cleavage is boxed. Either the bFU strand (lanes 1–7) or the G strand (lanes 8–14)
were 39 32P-end-labeled. Lanes: 1 and 8, A-specific sequencing reaction; 2 and 9, G-specific sequencing reaction. TDG concentrations: lanes 3 and 10,
0 nM; lanes 4 and 11, 0.25 nM; lanes 5 and 12, 0.75 nM; lanes 6 and 13, 2.5 nM; lanes 7 and 14, 7.5 nM. (B) Methylation interference footprinting of
the CpGybFU 54-mer. Parts of the sequences are shown along the gel. The position of the mismatched bases are denoted by arrows. An asterisk marks
the missing G-specific band. Either the bFU strand (lanes 1–4) or the G strand (lanes 5–8) were 39 32P-end-labeled. Lanes: 1 and 4, A-specific sequencing
reactions; 2 and 5, G-specific sequencing reactions; 3 and 7, cleavage pattern of the unbound 54-mer, isolated from the band with faster mobility in the
EMSA; 4 and 8, cleavage pattern of the bound 54-mer, isolated from the band with slower mobility in the EMSA. (C) Summary of binding interaction
between TDG and an oligonucleotide containing a bFUyGmismatch. The lines indicate the area protected by TDG from DNase I footprinting, and the
asterisk indicates the main contact determined by methylation interference footprinting.
Table 2. Dissociation constants for the binding of TDG to
oligonucleotides containing GybFU in various sequence contexts
Kd, pM Sequence
115 GpG/bFU
60 CpG/bFU
65 5meCpG/bFU
The Kd values were determined as described in Table 1.
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the results of which are summarized in Fig. 4C. Of special interest
are the results obtained usingmethylation interference analysis to
probe the interaction of TDG with the 7-position of G residues
in DNA. The G residue opposite the mismatched T appears not
to be directly contacted at N7, as evidenced by the lack of
apparent interference at that position (Fig. 4 B and C). Oligo-
nucleotides containing G residues synthetically modified at the
6-position—O6-methylGyT, 2-amino-6-methylaminopurineyT,
and 6-thioguanineyT mispairs—have been found to undergo
efficient processing by TDG (13), suggesting that the 6- and
possibly 1-positions are also unimportant for recognition by
TDG. Since the 6- and 7-positions are located in themajor groove
of B-DNA, it is possible that TDG recognizes the mismatched G
residue through interactions in the minor groove. Alternatively,
in light of recent results demonstrating (31, 32, 35, 36) or
suggesting (37–39) that DNA processing enzymes extrude the
substrate base or its pairing partner from the helix, it seems likely
that one or both of the residues in the GyT mismatch are
extrahelical when bound to TDG.
Programmed cytosine methylation in mammals occurs ex-
clusively in the CpG dinucleotide. Therefore, all TyG mis-
matches arising in the human genome through deamination of
m5CpG sites generate GyTpG sites (Fig. 1A). This being the
case, it has been suggested that TDGmight operate on GyTpG
in preference to GyTpC, GyTpT, or GyTpA. Indeed, recent
evidence indicates that TDG catalyzes excision on GyTpG
several-fold faster than on GyTpA and GyTpC, and roughly an
order of magnitude faster than on GyTpT (13). Our data
provide insight into the structural basis for this specificity.
Namely, in the frozen TDG–inhibitor complex, potent meth-
ylation interference is observed at the G residue in the
GybFUpG sequence, indicating that the proteinmakes a direct
(or water-mediated) contact to the N7-atom of this residue.
Assuming that the contacts to GybFUpG in the frozen com-
plex represent those established with GyTpG along the normal
catalytic pathway, we conclude that TDG recognizes deami-
nated m5CpG sites through a mechanism involving direct
selection in the major groove of the DNA. In addition to these
ground-state effects, it is also possible that TDG discriminates
for deaminated m5CpG sites in the transition state leading to
glycosidic bond cleavage (40). Consistent with the notion that
the contact between TDG and the 39-G contributes favorably
toward binding, we measured a Kd of 60 pM for the interaction
of TDG with an oligonucleotide containing a GybFUpG
sequence (Table 2), and could show that it displayed an affinity
roughly 2-fold higher than that measured for GybFUpT or
GybFUpG (Table 1 and 2). Interestingly, we found that the
affinity of TDG for bFUpG opposite CpGwas the same as that
for bFUpG opposite m5CpG; thus, TDG is insensitive to the
methylation state of the nondeaminated DNA strand.
In conclusion, we have shown that inhibitors of DNA
glycosylases provide a useful tool to study the interaction of
TDG with its DNA substrate. X-ray crystallographic studies of
these inhibitors bound to TDG are underway, and these should
provide detailed insights into the mechanism of sequence-
specific mismatch recognition and catalysis by TDG.
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